News and Announcements
Investors Share Advice On How To Navigate Investments in the Crypto Winter 🥶
- Published November 03, 2022 6:55AM UTC
- Publisher Maan Perez
- Categories Venture Investor Interviews
How should investors weather the crypto winter? 🥶
At #VentureandCapital2022 Sydney, we brought together the leading minds in #crypto investing across Australia and globally to help investors navigate the crypto market. 📈
Watch and gain insights from these industry leaders:
Adam Switzer – CEO of Leonie Hill AI
Ben Simpson – CEO – Collective Shift
Luke Jones – CFO at Rarestone Capital
Jacob Pritchard – Institutional Sales, Binance
Looking for new investment opportunities? Click here to browse hundreds of companies, connect with their CEO and create your personalised deal flow.
Your capital engagement platform
With a 14-year track record, a network of 32,000+ investors, and a capital raising platform, Wholesale investor is a leading investment platform for start-ups, scale-ups, emerging growth companies, and small caps.
Venture Investor Interviews
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Dying for a Cure: Why Astraea is Stress-Testing the Future of Space Medicine
Astraea Technologies is solving a critical “blind spot” in the $1.5T space economy. Co-founders Brooke Mills and Gordon Carroll discuss their $5M seed raise, the HIRO-LAB platform, and their upcoming 2028 mission to the Moon to validate life-saving medicine in extreme environments.
Beyond the Drip: Elemental IV’s Infrastructure Play for a Fragile Supply Chain
In the high-stakes world of life sciences, we often hunt for the next “miracle molecule” or gene-editing breakthrough. But Storme Paes, Founder and Commercial Director of Elemental IV, found her mission in something far more fundamental, yet dangerously overlooked: a simple bag of saltwater. The “Meeting Room” Revelation The genesis of Elemental IV didn’t occur […]
Backed By Leading Investment Groups and Family Offices
